Peptide Design and Optimization Services
Enhancing Peptide Molecule Activity and Functionality
At PeptiOrigin, we leverage our globally leading molecular optimization technology to design and refine peptides for enhanced activity, stability, and therapeutic functionality. Our proprietary peptide design and optimization services help accelerate drug discovery by tailoring peptides to meet specific biological and physicochemical requirements.
Through rational design, AI-driven modeling, and advanced chemical modifications, we ensure that each peptide candidate achieves optimal target engagement, bioavailability, and therapeutic efficacy while minimizing unwanted properties such as immunogenicity and degradation.
We provide comprehensive Peptide Design Services and Peptide Optimization Services to accelerate the development of potent and selective peptide therapeutics. Our integrated approach combines computational modeling, structural analysis, and experimental validation to ensure high efficiency at every stage of drug discovery.
Innovative Peptide Design
Our Peptide Design Services leverage advanced algorithms and structural biology insights to generate peptides with high affinity, specificity, and favorable pharmacokinetic properties. By integrating rational design strategies with AI-driven predictions, we facilitate the rapid identification of promising candidates for Peptide Drug Discovery programs.
Optimizing Peptide Performance
Through our Peptide Optimization Services, we refine lead peptides for enhanced stability, selectivity, and biological activity. This includes Peptide Structure Optimization, where three-dimensional conformations are fine-tuned to maximize target engagement, and Peptide Modification strategies, such as cyclization, lipidation, PEGylation, or other chemical modifications, to improve bioavailability and therapeutic potential.
Targeted and Conjugated Peptide Development
We specialize in Targeting Peptide Discovery, identifying peptides capable of selectively interacting with specific disease-related targets. Additionally, our expertise in Peptide Drug Conjugates (PDCs) and Radionuclide Drug Conjugates (RDCs) enables the design of conjugated therapeutics that combine peptides with cytotoxic agents or radioactive isotopes, enhancing efficacy while minimizing off-target effects.
By integrating Peptide Design Services, Peptide Optimization Services, and targeted conjugation strategies, PeptiOrigin accelerates the path from concept to lead peptide. Our multidisciplinary platform ensures that every peptide candidate is optimized for potency, selectivity, and clinical readiness, supporting the discovery of next-generation therapeutics.
Our Approach to Peptide Design & Optimization
1. Rational & AI-Driven Peptide Design
We integrate computational modeling, AI-driven sequence prediction, and structural analysis to design peptides with superior biological activity.
Target-Based Sequence Optimization:
Structure-guided modifications to enhance peptide-receptor binding.
Molecular Dynamics Simulations:
Predicting peptide stability, folding, and binding behavior in different environments.
Artificial Intelligence & Machine Learning:
Data-driven sequence prediction for improved efficacy and specificity.
De Novo Peptide Design:
Creating novel peptides tailored for unique therapeutic and cosmetic applications.
By combining bioinformatics, molecular docking, and deep-learning algorithms, we streamline the discovery of high-performing peptide candidates.
2. Chemical Modifications for Enhanced Peptide Performance
We employ advanced chemical modification strategies to improve the pharmacokinetics, stability, and cellular uptake of peptide molecules.
Peptide Cyclization:
Enhancing structural rigidity and target binding affinity.
N-terminal & C-terminal Modifications:
Increasing peptide resistance to enzymatic degradation.
Stapled Peptides & Helix Stabilization:
Strengthening secondary structures for intracellular targeting.
Lipidation & PEGylation:
Improving solubility, half-life, and membrane permeability.
Non-Natural Amino Acid Incorporation:
Expanding functional diversity and metabolic stability.
Our expertise in chemical engineering enables tailor-made modifications that maximize therapeutic efficacy and manufacturability.
3. Stability & Pharmacokinetic Optimization
Ensuring that peptides maintain bioactivity and structural integrity under physiological conditions is crucial for clinical development.
Enzymatic Stability Enhancement:
Resistance to proteolytic degradation in plasma and gastrointestinal conditions.
Half-Life Extension Strategies:
Prolonged circulation via albumin binding, PEGylation, or fusion strategies.
Cellular Uptake Optimization:
Improved permeability through lipid conjugation or cell-penetrating peptide tagging.
Solubility & Aggregation Control:
Custom formulation strategies to enhance solubility and prevent self-aggregation.
Through systematic structure-activity relationship (SAR) studies, we refine peptide candidates to achieve optimal in vivo performance.
4. High-Throughput Screening for Optimized Leads
Our multi-targeting drug discovery (MTDD) / high-throughput screening (HTS) platform evaluates peptide candidates across molecular and cell-based to rapidly identify the most promising lead compounds.
Biacore SPR Binding Kinetics Analysis:
Label-free, real-time interaction studies.
Cell-Based Functional Assays:
Target engagement and intracellular activity validation.
Using data-driven screening approaches, we ensure that only the most viable candidates move forward in development.
Other Services
Contact
We value your inquiries and feedback! Whether you’re looking for more information about our peptide library, services, or collaboration opportunities, our team is here to assist you.
中文 
